scispace - formally typeset
Open AccessJournal ArticleDOI

Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation.

Reads0
Chats0
TLDR
It is shown that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner, which may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.
Abstract
The intracellular levels of many proteins are regulated by ubiquitin-dependent proteolysis. One of the best-characterized enzymes that catalyzes the attachment of ubiquitin to proteins is a ubiquitin ligase complex, Skp1-Cullin-F box complex containing Hrt1 (SCF). We sought to artificially target a protein to the SCF complex for ubiquitination and degradation. To this end, we tested methionine aminopeptidase-2 (MetAP-2), which covalently binds the angiogenesis inhibitor ovalicin. A chimeric compound, protein-targeting chimeric molecule 1 (Protac-1), was synthesized to recruit MetAP-2 to SCF. One domain of Protac-1 contains the IκBα phosphopeptide that is recognized by the F-box protein β-TRCP, whereas the other domain is composed of ovalicin. We show that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner. In the future, this approach may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.

TL;DR: The experimental characterisation that validates the use of molecules that promote protein degradation as chemical tools is discussed, the preclinical and clinical examples disclosed to date, and the future prospects for this exciting area of chemical biology are discussed.
Journal ArticleDOI

Substrate selection by the proteasome during degradation of protein complexes

TL;DR: The degradation of model proteins is tested to reveal the molecular basis of subunit specificity in the degradation of protein complexes and provide a plausible explanation for how adaptor proteins can bind to otherwise stable proteins and target them for degradation.
Journal ArticleDOI

Engineering Signal Transduction Pathways

TL;DR: This review discusses the challenges associated with engineering signal transduction pathways and addresses advantages and disadvantages of engineering signaling pathways in prokaryotic and eukaryotic cells, highlighting recent examples.
Journal ArticleDOI

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.

TL;DR: The potential of PROTACs to become anticancer therapeutics, chemical and bioinformatics approaches for PROTAC design, and safety concerns are discussed with a special focus on the development of tumor-specific/selectiveprotACs.
Journal ArticleDOI

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.

TL;DR: These approaches are ripe for expanding the chemical space of PROTACs and usher in the advent of other emerging bifunctional modalities of proximity-based pharmacology.
References
More filters
Journal ArticleDOI

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

TL;DR: Recent progress has been made in understanding the details of the signaling pathways that regulate NF-kappaB activity, particularly those responding to the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1.
Journal ArticleDOI

IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation

TL;DR: In this article, a large multiprotein complex, the IkappaB kinase (IKK) signalsome, was purified from HeLa cells and found to contain a cytokine-inducible IKK kinase activity that phosphorylates IappaB-alpha and IKK-beta.
Journal ArticleDOI

SCF and Cullin/RING H2-Based Ubiquitin Ligases

TL;DR: This review is focused on a conserved ubiquitin ligase complex known as SCF that plays a key role in marking a variety of regulatory proteins for destruction by the 26S proteasome.
Journal ArticleDOI

Transduction of full-length TAT fusion proteins into mammalian cells:TAT-p27Kip1 induces cell migration

TL;DR: Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27 Kip1 induces cell migration and promotes cell migration in mice.
Journal ArticleDOI

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

TL;DR: In this article, the authors used biotinylated-epoxomicin as a molecular probe and showed that it covalently binds to the LMP7, X, MECL1, and Z catalytic subunits of the proteasome.
Related Papers (5)